Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPLEx Pays Dividends In Stopping Multi-State PSE Purchases

This article was originally published in The Tan Sheet

Executive Summary

The largest amount of NPLEx-stopped sales was in Texas – 209,000 grams or 82,000 boxes. “People who don’t know the tracking system is in effect are still trying to purchase over the legal limit across state lines,” says National Association of Drug Diversion Investigators Executive Director Charles Cichon.

You may also be interested in...



To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products

An HHS agency’s 2013 drug use survey shows the number of meth users rising by 155,000 after changing little the previous two years. Acura Pharmaceuticals notes the survey and Tennessee data showing that making only tamper-resistant, single-ingredient PSE products available affects the diversion rate.

To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products

An HHS agency’s 2013 drug use survey shows the number of meth users rising by 155,000 after changing little the previous two years. Acura Pharmaceuticals notes the survey and Tennessee data showing that making only tamper-resistant, single-ingredient PSE products available affects the diversion rate.

GAO Backs Prescription Pseudoephedrine Approach

Senator Feinstein says PSE products should be available only by prescription nationwide. A GAO report supports “an expansion of prescription-only laws in the fight to combat the serious epidemic of meth production,” she says.

Related Content

Topics

UsernamePublicRestriction

Register

PS105875

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel